The CMS says the University of Maryland Medical Center violated the Emergency Medical Treatment and Labor Act with its handling of a mentally ill patient who was found in just a gown and socks outside the center's midtown Baltimore campus on a freezing January night.
The CMS wants to hear from physicians about potential revisions to evaluation and management visit codes.
Several Idaho Republican officials met with CMS Administrator Seema Verma to persuade her to reconsider their "state-based plan" model, and they may consider suing if the agency continues blocking the proposal.
Allina's former vice president of talent and human resources, David Matthew Johnson, pleaded guilty to embezzling hundreds of thousands of dollars from the system.
University Hospitals now faces multiple lawsuits following an incident at its Fertility Clinic that compromised hundreds of eggs and embryos stored in liquid nitrogen.
Hospital lab personnel are asking the CMS to roll back a 2016 policy that allows nurses to analyze lab tests. The request comes as such tests become more complex and widely used.
The U.S. Justice Department will not intervene in a recently unsealed group of False Claims Act lawsuits alleging that HCR ManorCare admitted patients to hospice who were not eligible for the service.
As the House gears up for hearings on new 340B legislation, the Senate announces its initial major hearing on the drug discount program.
Insurer and provider groups railed against the CMS' proposal to use more patient-encounter data for Medicare Advantage plans' risk scores in 2019, but supported its suggestion to account for patients' mental health and substance abuse disorders.
The Food and Drug Administration has approved the first direct-to-consumer breast cancer gene test, but it will require 23andMe to warn consumers about the limitations of the genetic information.
The CMS will overhaul its meaningful-use initiative that compelled providers to adopt electronic health records. Medical stakeholders have been complaining for years that the program is burdensome and hard to implement by CMS deadlines.
A federal appeals court has requested additional information from the U.S. House of Representatives and HHS before it considers signing off on their settlement over cost-sharing reduction payments for insurers.